DiaSorin Receives FDA Approval On 6 Hepatitis B Tests
DiaSorin is now able to offer a complete testing solution for Hepatitis A, Hepatitis B, and Hepatitis C in the United States.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Hematology & Serology |
DiaSorin is now able to offer a complete testing solution for Hepatitis A, Hepatitis B, and Hepatitis C in the United States.
Read MorePosted by Laurie Bonner | Oct 6, 2020 | Company News, Covid 19 |
The addition of new, rapid point-of-care platforms will expand national testing options.
Read MorePosted by Laurie Bonner | Oct 3, 2020 | Covid 19, Molecular Diagnostics |
Researchers suggest the testing method would address needs in the developing world and in the United States, where reagent supplies are again dwindling.
Read MorePosted by Laurie Bonner | Oct 1, 2020 | Disease States |
More than just Lyme, a number of diseases spread by ticks are on the rise.
Read MorePosted by Laurie Bonner | Sep 29, 2020 | Diabetes & Metabolic Diseases, Hematology & Serology |
LabCorp will develop and commercialize a blood-based molecular diagnostic test powered by NIS4 technology to help identify patients with at-risk nonalcoholic steatohepatitis.
Read More